|
C7ORF28B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.711830E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.769020E-01 |
| Normal-vs-Stage2 |
1.011790E-01 |
| Normal-vs-Stage3 |
8.726000E-01 |
| Normal-vs-Stage4 |
1.944950E-01 |
| Stage1-vs-Stage2 |
4.861400E-01 |
| Stage1-vs-Stage3 |
2.763600E-01 |
| Stage1-vs-Stage4 |
8.005400E-01 |
| Stage2-vs-Stage3 |
1.352570E-01 |
| Stage2-vs-Stage4 |
6.580800E-01 |
| Stage3-vs-Stage4 |
2.546000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.865970E-01 |
| Normal-vs-AfricanAmerican |
7.578800E-01 |
| Normal-vs-Asian |
3.672200E-01 |
| Caucasian-vs-AfricanAmerican |
8.321200E-01 |
| Caucasian-vs-Asian |
4.472600E-01 |
| AfricanAmerican-vs-Asian |
3.228000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.946360E-01 |
| Normal-vs-Female |
2.546400E-01 |
| Male-vs-Female |
9.768000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.740200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.286620E-01 |
| Normal-vs-Age(61-80Yrs) |
2.974400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.746800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.236600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.252200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.144600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.678400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.278000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.589200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.869000E-01 |
| Normal-vs-Grade 2 |
7.343900E-02 |
| Normal-vs-Grade 3 |
4.873800E-01 |
| Normal-vs-Grade 4 |
8.132200E-01 |
| Grade 1-vs-Grade 2 |
4.002800E-01 |
| Grade 1-vs-Grade 3 |
3.271200E-01 |
| Grade 1-vs-Grade 4 |
2.718400E-01 |
| Grade 2-vs-Grade 3 |
2.033200E-01 |
| Grade 2-vs-Grade 4 |
7.908300E-02 |
| Grade 3-vs-Grade 4 |
3.962000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.897560E-01 |
| Normal-vs-ccB subtype |
3.891800E-01 |
| ccA subtype-vs-ccB subtype |
6.749600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.433700E-02 |
| Normal-vs-N1 |
4.465000E-01 |
| N0-vs-N1 |
9.805000E-01 |
|
|
